We are live on
!
Find out more
SC
Scholtz & Company Portfolio holdings
AUM
$195M
1-Year Est. Return
12.04%
This Fund
S&P 500
This Quarter
Est. Return
+15.52%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$229M
AUM Growth
+$28.6M
(+14%)
Cap. Flow
+$765K
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
47.77%
Holding
71
New
10
Increased
23
Reduced
33
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$2.88M |
| 2 |
Advanced Micro Devices
AMD
|
+$2.69M |
| 3 |
ASPU
ASPEN GROUP, INC.
ASPU
|
+$2.61M |
| 4 |
OrthoPediatrics
KIDS
|
+$629K |
| 5 |
XRN
Chiron Real Estate Inc
XRN
|
+$596K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$2.87M |
| 2 |
Air Products & Chemicals
APD
|
+$2.37M |
| 3 |
Burlington
BURL
|
+$1.46M |
| 4 |
Five Below
FIVE
|
+$969K |
| 5 |
Dollar General
DG
|
+$925K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.25% |
| 2 | Consumer Discretionary | 20.21% |
| 3 | Healthcare | 19.48% |
| 4 | Financials | 9.11% |
| 5 | Communication Services | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
B
51
Barrick Mining
B
$62.3B
| $450K | 0.2% |
16,025
+6,125
| +62% | +$174K |
|
52
State Street SPDR S&P 500 ETF Trust
SPY
$804B
| $417K | 0.18% |
1,246
-97
| -7% | -$32.1K |
|
53
Chipotle Mexican Grill
CMG
$47B
| $346K | 0.15% |
13,900
-2,800
| -17% | -$67.5K |
|
54
Illumina
ILMN
$30.7B
| $319K | 0.14% |
+1,061
| New | +$366K |
|
55
Accenture
ACN
$102B
| $315K | 0.14% |
1,396
+417
| +43% | +$95.5K |
|
56
Boeing
BA
$179B
| $315K | 0.14% |
1,906
| – | – |
|
|
DOCU
57
DocuSign
DOCU
$10.6B
| $304K | 0.13% |
+1,412
| New | +$293K |
|
58
Intuitive Surgical
ISRG
$133B
| $295K | 0.13% |
1,248
+183
| +17% | +$41.1K |
|
59
Meta Platforms (Facebook)
META
$1.51T
| $282K | 0.12% |
1,078
-1,153
| -52% | -$297K |
|
60
Lockheed Martin
LMT
$134B
| $262K | 0.11% |
683
-6
| -0.9% | -$2.29K |
|
|
NVTA
61
DELISTED
Invitae Corporation
NVTA
| $261K | 0.11% |
+6,030
| New | +$206K |
|
62
NVR
NVR
$16.5B
| $245K | 0.11% |
+60
| New | +$232K |
|
63
CRISPR Therapeutics
CRSP
$4.88B
| $215K | 0.09% |
+2,565
| New | +$228K |
|
64
Spero Therapeutics
SPRO
$69.5M
| $149K | 0.07% |
+13,330
| New | +$158K |
|
|
PRTK
65
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $88K | 0.04% |
16,195
-7,300
| -31% | -$36.1K |
|
|
66
Burlington
BURL
$23.2B
| – | – |
-7,409
| Closed | -$1.46M |
|
67
CVS Health
CVS
$134B
| – | – |
-5,168
| Closed | -$336K |
|
|
AKTS
68
DELISTED
Akoustis Technologies Inc
AKTS
| – | – |
-11,238
| Closed | -$93K |
|
Similar funds
MHFA
TF
RAM
ICMARC
CPRPA
CPI
MAMF
PAM
Scholtz & Company's Q3 2020 Portfolio in Review
As of Q3 2020, Scholtz & Company held 71 positions worth $229M, up 14% from $200M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Scholtz & Company's Q3 2020 filing shows 10 new, 23 increased, 33 reduced and 3 closed positions. Its largest new stake was Match Group: 27,215 shares worth $3.01M. The largest sale was People Inc, an estimated $2.87M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Scholtz & Company's largest Q3 2020 buy was Match Group: 27,215 shares worth $3.01M.
- Scholtz & Company added most to Advanced Micro Devices in Q3 2020, an estimated $2.69M increase.
- Scholtz & Company's biggest Q3 2020 reduction was People Inc, cutting an estimated $2.87M.
- Scholtz & Company fully exited Burlington in Q3 2020, selling an estimated $1.46M.
- Scholtz & Company's ten largest holdings make up 48% of its $229M portfolio in Q3 2020.
- Scholtz & Company opened 10 new positions and closed 3 in Q3 2020.
- Scholtz & Company's portfolio value rose 14% quarter-over-quarter to $229M.
Based on Scholtz & Company's 13F filing for Q3 2020, filed 16 Nov 2020.